Myocardial Adiponectin Isoform Shift in Dogs with Congestive Heart Failure—A Comparison to Hibernating Brown Bears (Ursus arctos horribilis)

• Published in: Veterinary Sciences
• Main Authors: O. Lynne Nelson, Rachael M. Wood, Jens Häggström, Clarence Kvart, Charles T. Robbins
• Format: Article in Journal/Newspaper
• Language: English
• Published: MDPI AG 2017
• Subjects: low molecular weight adiponectin; high molecular weight adiponectin; chronic valvular heart disease; endocardiosis; hibernation; Veterinary medicine; SF600-1100; Ursus arctos
• Online Access: https://doi.org/10.3390/vetsci4030035; https://doaj.org/article/c7cb49e92615468daf0cb90cb4b818ec

Adiponectin is the most abundant plasma adipokine, and is well known for its role in energy homeostasis and cardiac protection. In humans with dilated cardiomyopathy, myocardial adiponectin protein expression is reduced compared to normal hearts and has been implicated in the pathology of cardiomyopathy. Serum adiponectin levels are often conflicting, with higher levels associated with poor survival in humans with congestive heart failure (CHF). We evaluated adiponectin serum concentrations and myocardial protein expression in dogs with naturally occurring myxomatous mitral valve disease and CHF. We compared the findings to active and hibernating brown bears as bears are adapted to endure an extreme period of low cardiac output during their annual hibernation. Bears exhibited largely the active high-molecular weight (HMW) versus the low-molecular weight isoforms of myocardial adiponectin (HMW:LMW = 6.3) during both the active period and hibernation, while healthy dogs exhibited a more balanced mix of isoforms. Dogs with CHF expressed predominately HMW isoforms of adiponectin (HMW:LMW = 12.5), appearing more similar to bears. In contrast to humans, serum adiponectin was significantly lower in dogs with CHF and lowest levels in the severest CHF class. In both dogs and bears, myocardial adiponectin was expressed independent of circulating adiponectin concentrations, suggesting a local regulatory mechanism within the heart.